Precipio (PRPO) Stock Price Down 0.6%

Precipio Inc (NASDAQ:PRPO) was down 0.6% during mid-day trading on Monday . The company traded as low as $0.16 and last traded at $0.16. Approximately 700,145 shares changed hands during mid-day trading, a decline of 78% from the average daily volume of 3,117,182 shares. The stock had previously closed at $0.17.

The company has a current ratio of 0.14, a quick ratio of 0.13 and a debt-to-equity ratio of 0.30.

Precipio (NASDAQ:PRPO) last announced its quarterly earnings results on Monday, November 19th. The biotechnology company reported ($0.13) earnings per share (EPS) for the quarter. Precipio had a negative return on equity of 149.24% and a negative net margin of 610.39%. The firm had revenue of $0.65 million during the quarter.

COPYRIGHT VIOLATION NOTICE: “Precipio (PRPO) Stock Price Down 0.6%” was first published by Dakota Financial News and is the sole property of of Dakota Financial News. If you are reading this article on another domain, it was illegally copied and reposted in violation of U.S. & international trademark & copyright legislation. The correct version of this article can be accessed at https://dakotafinancialnews.com/2019/02/12/precipio-prpo-stock-price-down-0-6.html.



About Precipio (NASDAQ:PRPO)

Precipio, Inc, a cancer diagnostics company, provides diagnostic products and services to the oncology market. It also develops a platform to eradicate the problem of misdiagnosis within academic institutions. In addition, the company delivers diagnostic information to physicians and their patients. It has collaborations with academic institutions specializing in cancer research, diagnostics, and treatment, as well as PerkinElmer.

Featured Story: Cost of Debt

Receive News & Ratings for Precipio Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Precipio and related companies with MarketBeat.com's FREE daily email newsletter.

Leave a Reply